Exicure, Inc. (XCUR)Healthcare | Biotechnology | Redwood City, United States | NasdaqCM
1.15 USD
+0.06
(5.505%)
⇧
(Oct. 13, 2026, 4 p.m.
EDT)
After hours: 1.17 +0.02 (1.739%) ⇧ (Oct. 13, 2026, 6:35 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 6:54 a.m. EDT
The immediate outlook is severely bearish as the stock trades near its 52-week low of $0.94, having fallen nearly 99% from its October 2025 peak of $4.95. Despite a recent year-over-year price rebound, the underlying business is in freefall, burning through cash with negative operating flows of $6.7 million and a massive debt-to-equity burden implied by a current ratio of just 0.56. The company faces an existential threat with a Nasdaq delisting warning due to insufficient equity, and the statistical forecast models predict further downside over the next month. There is no dividend to provide any cushion, and the balance sheet shows no signs of the fortress-like strength required for a turnaround. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.090367 |
| AutoARIMA | 0.226697 |
| AutoETS | 0.226699 |
| MSTL | 0.242340 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 4.53 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.312 |
| Excess Kurtosis | -1.10 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 7,527,894 |
| Forward P/E | -1.49 |
| Beta | 3.64 |
| Website | https://www.exicuretx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.78585464 |
| Address1 | 400 Seaport Court |
| Address2 | Suite 102 |
| All Time High | 975.0 |
| All Time Low | 0.936 |
| Ask | 1.71 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 43,960 |
| Average Daily Volume3 Month | 206,985 |
| Average Volume | 206,985 |
| Average Volume10Days | 43,960 |
| Beta | 3.636 |
| Bid | 1.78 |
| Bid Size | 1 |
| Board Risk | 10 |
| Book Value | 0.329 |
| City | Redwood City |
| Compensation Risk | 7 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.15 |
| Current Ratio | 0.557 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.21 |
| Day Low | 1.09 |
| Display Name | Exicure |
| Dividend Yield | 0.0 |
| Earnings Timestamp End | 1,755,259,200 |
| Earnings Timestamp Start | 1,754,909,940 |
| Ebitda | -7,110,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.817 |
| Enterprise Value | 5,810,894 |
| Eps Forward | -0.77 |
| Eps Trailing Twelve Months | -1.31 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.2798 |
| Fifty Day Average Change | -0.12980008 |
| Fifty Day Average Change Percent | -0.10142215 |
| Fifty Two Week Change Percent | -78.585464 |
| Fifty Two Week High | 9.48 |
| Fifty Two Week High Change | -8.33 |
| Fifty Two Week High Change Percent | -0.87869203 |
| Fifty Two Week Low | 0.936 |
| Fifty Two Week Low Change | 0.21399999 |
| Fifty Two Week Low Change Percent | 0.22863247 |
| Fifty Two Week Range | 0.936 - 9.48 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,526,995,800,000 |
| Float Shares | 3,096,125 |
| Forward Eps | -0.77 |
| Forward P E | -1.4935066 |
| Free Cashflow | -3,618,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 1 |
| Fullday Change | 0.07999992 |
| Fullday Change Percent | 7.3394423 |
| Fullday Price | 1.15 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.0 |
| Gross Profits | 1,257,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.41472998 |
| Held Percent Institutions | 0.0225 |
| Implied Shares Outstanding | 6,545,995 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,724,803,200 |
| Last Split Factor | 1:5 |
| Long Business Summary | Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. |
| Long Name | Exicure, Inc. |
| Market | us_market |
| Market Cap | 7,527,894 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_82271676 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -8,284,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 8,247,953 |
| Open | 1.12 |
| Operating Cashflow | -6,704,000 |
| Operating Margins | 0.0 |
| Overall Risk | 10 |
| Payout Ratio | 0.0 |
| Phone | 847 673 1700 |
| Post Market Change | 0.01999998 |
| Post Market Change Percent | 1.7391288 |
| Post Market Price | 1.17 |
| Post Market Time | 1,791,930,959 |
| Previous Close | 1.09 |
| Price Hint | 4 |
| Price To Book | 3.4954407 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.414 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.059999943 |
| Regular Market Change Percent | 5.504582 |
| Regular Market Day High | 1.21 |
| Regular Market Day Low | 1.09 |
| Regular Market Day Range | 1.09 - 1.21 |
| Regular Market Open | 1.12 |
| Regular Market Previous Close | 1.09 |
| Regular Market Price | 1.15 |
| Regular Market Time | 1,791,921,600 |
| Regular Market Volume | 23,143 |
| Return On Assets | -0.30318 |
| Return On Equity | -1.6837399 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 6,545,995 |
| Shares Percent Shares Out | 0.0057 |
| Shares Short | 37,561 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 50,826 |
| Short Name | Exicure, Inc. |
| Short Percent Of Float | 0.0117 |
| Short Ratio | 1.22 |
| Source Interval | 15 |
| State | CA |
| Symbol | XCUR |
| Total Cash | 1,717,000 |
| Total Cash Per Share | 0.262 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.31 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.04678 |
| Two Hundred Day Average Change | -1.8967801 |
| Two Hundred Day Average Change Percent | -0.62255234 |
| Type Disp | Equity |
| Volume | 23,143 |
| Website | https://www.exicuretx.com |
| Zip | 94,063 |